{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:17:21Z","timestamp":1788585441145,"version":"build-2803163510"},"reference-count":34,"publisher":"The Society for Free Radical Research Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2026,9,1]]},"DOI":"10.3164\/jcbn.25-276","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T22:09:48Z","timestamp":1779833388000},"page":"131-140","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the potential targets and molecular mechanisms of cordycepin against gastric cancer based on bioinformatics analysis and network pharmacology"],"prefix":"10.3164","volume":"79","author":[{"given":"Zijing","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Oncology, Xi Dian Group Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiqing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine Physiotherapy, Guilin Rehabilitation Recuperate Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Xi Dian Group Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Sundar R, Nakayama I, Markar SR, et al. Gastric cancer. Lancet 2025; 405: 2087\u20132102.","DOI":"10.1016\/S0140-6736(25)00052-2"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Huang Y, Shao Y, Yu X, Chen C, Guo J, Ye G. Global progress and future prospects of early gastric cancer screening. J Cancer 2024; 15: 3045\u20133064.","DOI":"10.7150\/jca.95311"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Tao L, Zeng P, Yuan X, et al. The application of immunoprotein inhibitor treatment regimens based on PD-L1: a retrospective analysis after the progression of advanced gastric cancer. Lett Drug Design Discov 2025; 22: 100127.","DOI":"10.1016\/j.lddd.2025.100127"},{"key":"4","unstructured":"4 Mott T, Gray C. Gastric cancer: rapid evidence review. Am Fam Physician 2025; 111: 140\u2013145."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Chen Y, Jia K, Xie Y, et al. The current landscape of gastric cancer and gastroesophageal junction cancer diagnosis and treatment in China: a comprehensive nationwide cohort analysis. J Hematol Oncol 2025; 18: 42.","DOI":"10.1186\/s13045-025-01698-y"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Hashem S, Ali TA, Akhtar S, et al. Targeting cancer signaling pathways by natural products: exploring promising anti-cancer agents. Biomed Pharmacother 2022; 150: 113054.","DOI":"10.1016\/j.biopha.2022.113054"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Zhou Y, Peng S, Wang H, Cai X, Wang Q. Review of personalized medicine and pharmacogenomics of anti-cancer compounds and natural products. Genes (Basel) 2024; 15: 468.","DOI":"10.3390\/genes15040468"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Kraim K, Boudjedir A, Saihi Y, Oueld Chikh FZ, Slatnia Y, Ferkous F. <i>In silico<\/i> structure-based screening of potential anticancer bioactive natural constituents from african natural products. Lett Drug Design Discov 2024; 21: 3479\u20133492.","DOI":"10.2174\/0115701808280302240117055932"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Khan MA, Tania M. Cordycepin and kinase inhibition in cancer. Drug Discov Today 2023; 28: 103481.","DOI":"10.1016\/j.drudis.2022.103481"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Chen M, Luo J, Jiang W, Chen L, Miao L, Han C. Cordycepin: a review of strategies to improve the bioavailability and efficacy. Phytother Res 2023; 37: 3839\u20133858.","DOI":"10.1002\/ptr.7921"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Yu G, Peng J, Li L, Yu W, He B, Xie B. The role and mechanisms of cordycepin in inhibiting cancer cells. Braz J Med Biol Res 2024; 57: e13889.","DOI":"10.1590\/1414-431x2024e13889"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Thepmalee C, Jenkham P, Ramwarungkura B, et al. Enhancing cancer immunotherapy using cordycepin and <i>Cordyceps militaris<\/i> extract to sensitize cancer cells and modulate immune responses. Sci Rep 2024; 14: 21907.","DOI":"10.1038\/s41598-024-72833-x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Zhang Z, Li K, Zheng Z, Liu Y. Cordycepin inhibits colon cancer proliferation by suppressing MYC expression. BMC Pharmacol Toxicol 2022; 23: 12.","DOI":"10.1186\/s40360-022-00551-z"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Ma X, Li Z, Cheng J, et al. Cordycepin inhibits cell proliferation, metastasis and aerobic glycolysis of gallbladder cancer by inactivating TOP2A-related pathway. Lett Drug Design Discov 2025; 22: 100044.","DOI":"10.1016\/j.lddd.2025.100044"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Kong W, Liu W, Wang M, et al. Cordycepin exhibits anti-bacterial and anti-inflammatory effects against gastritis in <i>Helicobacter pylori<\/i>-infected mice. Pathog Dis 2022; 80: ftac005.","DOI":"10.1093\/femspd\/ftac005"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Zhao X, Xiu J, Yang H, Han W, Jin Y. Network pharmacology and bioinformatics study of six medicinal food homologous plants against colorectal cancer. Int J Mol Sci 2025; 26: 930.","DOI":"10.3390\/ijms26030930"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Yu Y, Li L, Luo B, et al. Predicting potential therapeutic targets and small molecule drugs for early-stage lung adenocarcinoma. Biomed Pharmacother 2024; 174: 116528.","DOI":"10.1016\/j.biopha.2024.116528"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Feng B, Liang J, Cai X, et al. Elucidating the therapeutic mechanisms of <i>Angelica dahurica<\/i> in knee osteoarthritis: an integrative network pharmacology and molecular docking approach. Curr Proteomics 2025; 22: 100017.","DOI":"10.1016\/j.curpro.2025.100017"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Liu Z, Huang H, Yu Y, Li L, Shi X, Wang F. Exploring the mechanism of ellagic acid against gastric cancer based on bioinformatics analysis and network pharmacology. J Cell Mol Med 2023; 27: 3878\u20133896.","DOI":"10.1111\/jcmm.17967"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Liu Z, Huang H, Yu Y, et al. Exploring the potential mechanism of action of ursolic acid against gastric cancer and COVID-19 using network pharmacology and bioinformatics analysis. Curr Pharm Des 2023; 29: 1274\u20131292.","DOI":"10.2174\/1381612829666230510124716"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Zhang H, Liu M, Zhong H, et al. Mechanistic role of FN1 in LAIR-1 mediated downregulation of ovarian cancer cell proliferation. BMC Cancer 2025; 25: 339.","DOI":"10.1186\/s12885-025-13692-1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Zhang H, Chen X, Xue P, Ma X, Li J, Zhang J. FN1 promotes chondrocyte differentiation and collagen production via TGF-\u03b2\/PI3K\/Akt pathway in mice with femoral fracture. Gene 2021; 769: 145253.","DOI":"10.1016\/j.gene.2020.145253"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Li J, Chen C, Chen B, Guo T. High FN1 expression correlates with gastric cancer progression. Pathol Res Pract 2022; 239: 154179.","DOI":"10.1016\/j.prp.2022.154179"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Qin Z, Zhou C. HOXA13 promotes gastric cancer progression partially via the FN1-mediated FAK\/Src axis. Exp Hematol Oncol 2022; 11: 7.","DOI":"10.1186\/s40164-022-00260-7"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Yu X, Qin W, Cai H, et al. Analyzing the molecular mechanism of xuefuzhuyu decoction in the treatment of pulmonary hypertension with network pharmacology and bioinformatics and verifying molecular docking. Comput Biol Med 2024; 169: 107863.","DOI":"10.1016\/j.compbiomed.2023.107863"},{"key":"26","unstructured":"26 Xu J, Shen X, Sun D, Zhu Y. Cordycepin suppresses the malignant phenotypes of colon cancer cells through the GSK3\u00df\/\u00df-catenin\/cyclin D1 signaling pathway. Cell J 2022; 24: 255\u2013260."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Bhattarai P, Gunasekaran TI, Belloy ME, et al. Rare genetic variation in fibronectin 1 (FN1) protects against APO\u03b54 in Alzheimer\u2019s disease. Acta Neuropathol 2024; 147: 70.","DOI":"10.1007\/s00401-024-02721-1"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Chen T, Song P, He M, et al. Sphingosine-1-phosphate derived from PRP-Exos promotes angiogenesis in diabetic wound healing via the S1PR1\/AKT\/FN1 signalling pathway. Burns Trauma 2023; 11: tkad003.","DOI":"10.1093\/burnst\/tkad003"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Liu M, Chen P, Wei B, et al. FN1 shapes the behavior of papillary thyroid carcinoma through alternative splicing of EDB region. Sci Rep 2025; 15: 327.","DOI":"10.1038\/s41598-024-83369-5"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Chen C, Shen Z. FN1 promotes thyroid carcinoma cell proliferation and metastasis by activating the NF-\u03bab pathway. Protein Pept Lett 2023; 30: 54\u201364.","DOI":"10.2174\/0929866530666221019162943"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Zhang XX, Luo JH, Wu LQ. FN1 overexpression is correlated with unfavorable prognosis and immune infiltrates in breast cancer. Front Genet 2022; 13: 913659.","DOI":"10.3389\/fgene.2022.913659"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Zhang X, Jin M, Yao X, et al. Upregulation of LncRNA WT1-AS inhibits \u200dtumor growth and promotes autophagy in gastric cancer via suppression of PI3K\/Akt\/mTOR pathway. Curr Mol Pharmacol 2024; 17: e18761429318398.","DOI":"10.2174\/0118761429318398240918063450"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Zhang M, Wang Y, Sun Z, et al. Cordycepin potentiates photodynamic therapy efficacy in esophageal cancer cells via Modulation of the PI3K\/AKT\/FOXO3 signaling pathway. Photodiagnosis Photodyn Ther 2025; 55: 104725.","DOI":"10.1016\/j.pdpdt.2025.104725"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Lin Y, Li Y, Chen X, et al. YY1 mediated DCUN1D5 transcriptional activation promotes triple-negative breast cancer progression by targeting FN1\/PI3K\/AKT pathway. Biol Direct 2024; 19: 42.","DOI":"10.1186\/s13062-024-00481-2"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/79\/2\/79_25-276\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:50:35Z","timestamp":1788583835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/79\/2\/79_25-276\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.25-276","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"25-276"}}